The Canadian Society of Allergy and Clinical Immunology (CSACI) is currently developing Canadian clinical practice guidelines on the treatment of IgE-mediated food allergies with oral immunotherapy. This project is managed by an executive committee appointed by the CSACI with the methodological support of Quebec’s National Institute of Excellence in Health and Social Services (INESSS) as well as the Health Technology Assessment unit of Montreal’s Sainte-Justine University Hospital Center.

Oral immunotherapy involves the regular ingestion of precisely measured and increasing quantities of the allergy-causing food in order to progressively increase the patient’s tolerance, which, in time, may reduce the risk of allergic reactions or allow integrating the food into the diet. The guidelines will provide guidance for the safe, effective and efficient provision of oral immunotherapy to patients affected with allergies against eggs, peanuts, milk, wheat, soy, tree nuts, or other foods.

If you are a patient, or a caregiver (e.g., a parent) of a patient with food allergies, we would like to invite you to share your experiences and perspective. Your knowledge is important for us to better understand the context and situation of patients with food allergies. Through your participation, you will provide an important input to the clinical practice guidelines we are developing.

If you are interested, please complete the following 5-minute questionnaire here. This preliminary data will allow us to ensure diversity and representativeness of the persons we are consulting. Note that therefore not all persons who have completed this questionnaire will necessarily be contacted.

The deadline to respond to this invitation is Friday, June 28th, 2019.

La Société canadienne d'allergie et d'immunologie clinique (SCAIC) élabore actuellement des lignes directrices de pratique clinique canadiennes sur le traitement des allergies alimentaires à médiation IgE par l’immunothérapie orale. Ce projet est géré par un comité exécutif nommé par le CSACI avec l'appui méthodologique de l'Institut national d'excellence en santé et en services sociaux (INESSS) du Québec ainsi que de l'Unité d'évaluation des technologies de la santé du Centre hospitalier universitaire Sainte-Justine de Montréal.